Literature DB >> 10427822

[Liposarcoma of the spermatic cord: a report of a new case and a review of the literature].

J L Soler Soler1, A Zuluaga Gómez, M R Hidalgo Domínguez, M P Bados Nieto, J L Martínez Torres, A de la Fuente Serrano, M Nogueras Ocaña.   

Abstract

Malignant paratesticular tumors are uncommon. Of these, liposarcoma of the spermatic cord constitutes a rare tumor. Only a hundred cases have been reported. They are typically presented in elderly people. The usually have a good prognosis because of their low level of malignancy and their relapses tend to be localized. It has a high rate of survival over 5 years. Preoperative diagnosis is infrequent, it is suggested by the appearance of a progressively enlarging mass in the scrotum and the ultrasonography which shows a solid mass of the spermatic cord that is independent of the testicle. The choice treatment is radical orchidectomy, while long-term follow-up of these patients is mandatory because of local relapses. When local relapses become evident, the choice treatment is extensive local excision followed by adjuvant radiotherapy. In the present study we report a new case of a recurring, well differentiated spermatic cord liposarcoma of the type sclerotic, in a 50-year-old man. An exhaustive review of the literature has been made.

Entities:  

Mesh:

Year:  1999        PMID: 10427822

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  3 in total

1.  [Liposarcoma of the spermatic cord: a case report].

Authors:  H Zhao; L Zhou; X Chen; Y Liu
Journal:  Urologe A       Date:  2011-05       Impact factor: 0.639

2.  Synchronous testicular liposarcoma and prostate adenocarcinoma: a case report.

Authors:  Umut Demirci; Suleyman Buyukberber; Asli Cakir; Banu Ozturk; Nalan Akyurek; Basak Unver; Meltem Baykara; Mustafa Benekli; Ugur Coskun
Journal:  Cases J       Date:  2010-01-14

3.  Paratesticular liposarcoma; a case report.

Authors:  Shapour Omidvari; Seyyed Hasan Hamedi; Leila Moaddab-Shoar; Hamid Nasrollahi; Yahya Daneshbod; Mohammad Amin Mosleh-Shirazi; Mansour Ansrai; Mohammad Mohammadianpanah; Niloofar Ahmadloo; Ahmad Mosalaei
Journal:  Iran J Cancer Prev       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.